Skip to content

The effect of dietary flaxseed on Obesity

Comparison of the effect of dietary flaxseed and placebo on serum adiponectin, leptin, lipid profile and anthropometric indices among overweight or obese women: a clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016050327733N1
Enrollment
60
Registered
2017-02-08
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group: They will use 25g/day milled brown flaxseed in addition to weight loss diet for 12 weeks. Intervention 2: Control group: They will use 25g/day raw rice flour in ad
Placebo
Intervention group: They will use 25g/day milled brown flaxseed in addition to weight loss diet for 12 weeks
Control group: They will use 25g/day raw rice flour in addition to weight loss diet for 12 weeks

Sponsors

Vice Chancellor for research of Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women between 20-50 years old; body mass index over 25 kg and less than 40 kg, he no history of alcohol abuse or using alcohol less than 10 mg per day for women and less than 20 mg per day in men. Exclusion criteria: taking any medication or supplements that affect fat metabolism in the body and affect weight loss during last 3 months; history of allergy to flax seed; clinical diagnosis of kidney dysfunction, liver, heart, thyroid; history of cardiovascular disease, cancer, diabetes, gastrointestinal disorders that affect absorbtion; pregnancy; lactation; not willingness to cooperate.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Low density lipoprotein. Timepoint: At the beginning of study and 12th week of study. Method of measurement: Auto analysis mashine and calroimetry method.;Weight. Timepoint: At the beginning of study after 8 week and at the end of intervention. Method of measurement: Tape measurment,scale.;Height. Timepoint: At the beginning of study. Method of measurement: Tape measurement scale.;Adiponectin. Timepoint: At the beginning of study and 12 weeks after intervention. Method of measurement: ELISA method.;Leptin. Timepoint: At the beginning of study and 12th week of study. Method of measurement: ELISA method.;Triglycerid. Timepoint: At the beginng and 12th week after intervention. Method of measurement: Auto analyser device and Calorimetriy method.;Total cholesterol. Timepoint: At the beginng and 12th week after intervention. Method of measurement: Auto analyser device and Calorimetriy method.;High density lipoprotein. Timepoint: At the beginng and 12th week after intervention. Method of measurement: Auto analyser device and Calorimetriy method.;Waist circumference. Timepoint: At the beginning and end of study. Method of measurement: Tape measurement scale.;Hip circumference. Timepoint: At the beginning and end of study. Method of measurement: Tape measurement scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHoda Ahmadniay Motlagh

School of Nutrition and Food Sciences of Shiraz

stud2460058039@sums.ac.ir; hoda.ahmadnia@gmail.com+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026